切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2018, Vol. 07 ›› Issue (01) : 83 -86. doi: 10.3877/cma.j.issn.2095-3224.2018.01.018

所属专题: 经典病例 文献

教训与反思

直肠腺癌合并原发性肝脏神经内分泌癌一例
陈颖1, 孟雅楠1, 刘云鹏1, 刘静1, 金波1,()   
  1. 1. 110001 沈阳,中国医科大学附属第一医院肿瘤内科
  • 收稿日期:2017-07-27 出版日期:2018-02-25
  • 通信作者: 金波
  • 基金资助:
    辽宁省中央引导地方科技发展专项资金(No.2016007010); 辽宁省科学技术计划项目(No.2014226033、No.2014225013); 辽宁省卫生计生委赞助项目(No.LNCCC-D07-2015)

A case report of rectal adenocarcinoma with primary neuroendocrine carcinoma of the liver

Ying Chen1, Yanan Meng1, Yunpeng Liu1, Jing Liu1, Bo Jin1,()   

  1. 1. Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China
  • Received:2017-07-27 Published:2018-02-25
  • Corresponding author: Bo Jin
  • About author:
    Corresponding author: Jin Bo, Email:
引用本文:

陈颖, 孟雅楠, 刘云鹏, 刘静, 金波. 直肠腺癌合并原发性肝脏神经内分泌癌一例[J/OL]. 中华结直肠疾病电子杂志, 2018, 07(01): 83-86.

Ying Chen, Yanan Meng, Yunpeng Liu, Jing Liu, Bo Jin. A case report of rectal adenocarcinoma with primary neuroendocrine carcinoma of the liver[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(01): 83-86.

原发性肝脏神经内分泌癌较为少见,临床表现和影像学不具有特异性,病理诊断为金标准。该病例中患者同时伴有直肠腺癌,在初诊时肝内病灶考虑肠癌转移。在肝脏病灶与直肠病灶评效不一致后,我们行肝脏病灶穿刺病理证实为原发性肝脏神经内分泌癌,但由于患者肝功异常及体力下降未再有治疗机会。该病例提示我们临床工作中需要警惕患者存在多重癌可能,并且获得病理诊断很重要。

Primary hepatic neuroendocrine carcinoma is a rare disease and is short of specific clinical and imaging features. The pathological diagnosis is the gold standard. In this case, the patient presented with rectal adenocarcinoma with multiple liver lesions, which were thought as metastases from rectal cancer. Under the treatment, the primary rectal tumor responded well to the chemotherapy, while the liver lesions progressed rapidly. A biopsy to the liver was then performed, and the pathologic diagnosis revealed primary hepatic neuroendocrine carcinoma. Because of abnormal liver function and poor performance status, the patient was not tolerable for further treatment. This case indicated that we should be aware of the posibility of multiple cancers in clinical work.

图1 腹部增强CT表现:图1A1,1B1,1C1,2016年5月3日治疗前肝脏病灶;图2A2,2B2,2C2,2016年6月27日XELOX化疗2周期后肝脏病灶评效疾病进展;图3A3,3B3,3C3,2016年7月24日患者死亡前1天检查,提示疾病再次进展
图2 直肠及肝脏病变病理结果:2A直肠腺癌HE染色;2B肝脏穿刺标本HE40倍;2C肝穿刺标本免疫组化GgA(+);2D肝脏穿刺标本免疫组化CD56(+);2E肝脏穿刺标本HE20倍;2F肝脏穿刺病理免疫Ki67(+75%)
[1]
ParK CH, Chung JW, Jang SJ, et al. Clinical features and outcomes of primary hepatic neuroendocrine carcinomas [J]. J Gastroenterol Hepatol, 2012, 27(8): 1306-1311.
[2]
陈万青,郑荣寿,曾红梅, 等. 1989-2008年中国恶性肿瘤发病趋势分析 [J]. 中华肿瘤杂志, 2012, 34(7): 517-524.
[3]
Mima K, Beppu T, Murata A, et al. Primary neuroendocrine tumor in the liver treated by hepatectomy: report of a case [J]. Surg Today, 2011, 41(12): 1655-1660.
[4]
Hasegawa H, Kuzushita N, Nakazuru S, et al. Case of primaryhepatic neuroendocrine carcinoma diagnosed by needle biopsy [J]. Nihon Shokakibyo Gakkai Zasshi, 2010, 107(12): 1956-1962.
[5]
Volante M, Righi L, Berruti A, et al. The pathological diagnosis Of neuroendocrine tumors: common questions and tentative answers [J]. Virchows Arch, 2011, 458(4): 393-402.
[6]
Huang YQ, Xu F, Yang JM, et al. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases [J]. Hepatobiliary Pancreat Dis Int, 2010, 9(1): 44-48.
[7]
Van der Hoef M, Crook DW, Marincek B, et al. Primary neuroendocrine tumors of the liver: MRI features in two cases [J]. Abdom Imaging, 2004, 29(1): 77-81.
[8]
Kong W, Qiu Y, Zhang W, et al. Diagnosis of primary hepatic carcinoid tumor: report of one case [J]. Chin-Ger J Clin Oncol , 2008, 7(11): 673-675.
[9]
Chen Z, Xiao HE, Ramchandra P, et al. Imaging and pathological features of primary hepatic neuroendocrine carci- noma: an analysis of nine cases and review of the literature [J]. Oncol Lett, 2014, 7(4): 956-962.
[10]
Yao J, Hassan MA, Dagohoy C, et al. One hundred years after ″carcinoid″: epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in the United States [J]. J Clini Oncol, 2008, 26(18): 3063-3072.
[11]
许加刚,李伟,李玲. 47例原发性肝神经内分癌的临床分析 [J]. 中国现代医学, 2013, 51(4): 61-63.
[1] 王振宁, 杨康, 王得晨, 邹敏, 归明彬, 王雅楠, 徐明. 机器人与腹腔镜手术联合经自然腔道取标本对中低位直肠癌患者远期疗效比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 437-442.
[2] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[3] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[4] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[5] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[6] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[7] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[8] 郑民华, 蒋天宇, 赵轩, 马君俊. 中国腹腔镜直肠癌根治术30年发展历程与未来[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 591-595.
[9] 池畔, 黄胜辉. 中国腹腔镜直肠癌根治术30年来的巨大进步[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 596-600.
[10] 李明, 屠松, 闫鹏, 钱军, 高鹏程, 许文山, 杨发英, 胡振涛, 单永玮. 应用前列腺电切镜引导置管治疗直肠低位吻合口漏研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 603-606.
[11] 李玲, 刘亚, 李培玲, 张秀敏, 李萍. 直肠癌患者术后肠道菌群的变化与抑郁症相关性研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 607-610.
[12] 赵梓竣, 兰运升. 改良一针法末端回肠造口术对低位直肠癌保肛术后应激反应及安全性的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 611-614.
[13] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[14] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[15] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?